{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:58:19Z","timestamp":1790740699073,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"a Korea University Grant"},{"name":"a grant from Korea University Anam Hospital"},{"name":"the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education","award":["NRF-2015R1D1A1A02061859"],"award-info":[{"award-number":["NRF-2015R1D1A1A02061859"]}]},{"name":"the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT, & Future Planning","award":["NRF-2012R1A1A1013260"],"award-info":[{"award-number":["NRF-2012R1A1A1013260"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Being obese or underweight, and having diabetes are important risk factors for new-onset atrial fibrillation (AF). However, it is unclear whether there is any interaction between body weight and diabetes in regard to development of new-onset AF. We aimed to evaluate the role of body weight status and various stage of diabetes on new-onset AF.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a nationwide population based study using National Health Insurance Service (NHIS) data. A total of 9,797,418 patients who underwent national health check-ups were analyzed. Patients were classified as underweight [body mass index (BMI)\u2009&lt;\u200918.5], normal reference group (18.5\u2009\u2264\u2009BMI\u2009&lt;\u200923.0), upper normal (23.0\u2009\u2264\u2009BMI\u2009&lt;\u200925.0), overweight (25.0\u2009\u2264\u2009BMI\u2009&lt;\u200930.0), or obese (BMI\u2009\u2265\u200930.0) based on BMI. Diabetes were categorized as non-diabetic, impaired fasting glucose (IFG), new-onset diabetes, diabetes &lt;\u20095\u00a0years, and diabetes \u2265\u20095\u00a0years. Primary outcome end point was new-onset AF. New-onset AF was defined as one inpatient or two outpatient records of International Classification of Disease, Tenth Revision (ICD-10) codes in patients without prior AF diagnosis.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During 80,130,161 patient*years follow-up, a total of 196,136 new-onset AF occurred. Obese [hazard ration (HR)\u2009=\u20091.327], overweight (HR\u2009=\u20091.123), upper normal (HR\u2009=\u20091.040), and underweight (HR\u2009=\u20091.055) patients showed significantly increased risk of new-onset AF compared to the normal reference group. Gradual escalation in the risk of new-onset AF was observed along with advancing diabetic stage. Body weight status and diabetes were independently associated with new-onset AF and at the same time, had synergistic effects on the risk of new-onset AF with obese diabetic patients having the highest risk (HR\u2009=\u20091.823).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with obesity, overweight, underweight, and diabetes had significantly increased risk of new-onset AF. Body weight status and diabetes had synergistic effects on the risk of new-onset AF. The risk of new-onset AF increased gradually with advancing diabetic stage. This study suggests that maintaining optimal body weight and glucose homeostasis might prevent new-onset AF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-019-0932-z","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T14:09:18Z","timestamp":1569938958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study"],"prefix":"10.1186","volume":"18","author":[{"given":"Yun Gi","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-508X","authenticated-orcid":false,"given":"Jong-Il","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Yung","family":"Boo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Kyu","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-No","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaemin","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"issue":"9","key":"932_CR1","doi-asserted-by":"publisher","first-page":"e0163755","DOI":"10.1371\/journal.pone.0163755","volume":"11","author":"YG Kim","year":"2016","unstructured":"Kim YG, Shim J, Choi JI, Kim YH. Radiofrequency catheter ablation improves the quality of life measured with a short form-36 questionnaire in atrial fibrillation patients: a systematic review and meta-analysis. PLoS ONE. 2016;11(9):e0163755.","journal-title":"PLoS ONE"},{"issue":"8","key":"932_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129(8):837\u201347.","journal-title":"Circulation"},{"issue":"2","key":"932_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","volume":"114","author":"Y Miyasaka","year":"2006","unstructured":"Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119\u201325.","journal-title":"Circulation"},{"issue":"5","key":"932_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","volume":"113","author":"S Stewart","year":"2002","unstructured":"Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study. Am J Med. 2002;113(5):359\u201364.","journal-title":"Am J Med"},{"issue":"2","key":"932_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jacc.2003.08.037","volume":"43","author":"VE Hagens","year":"2004","unstructured":"Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the rate control versus electrical cardioversion (RACE) study. J Am Coll Cardiol. 2004;43(2):241\u20137.","journal-title":"J Am Coll Cardiol."},{"key":"932_CR6","doi-asserted-by":"crossref","unstructured":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154(13):1449\u201357.","DOI":"10.1001\/archinte.1994.00420130036007"},{"issue":"19","key":"932_CR7","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369\u2013429.","journal-title":"Eur Heart J"},{"issue":"12","key":"932_CR8","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","volume":"109","author":"SD Corley","year":"2004","unstructured":"Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004;109(12):1509\u201313.","journal-title":"Circulation"},{"issue":"5","key":"932_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417\u201327.","journal-title":"N Engl J Med"},{"issue":"31","key":"932_CR10","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","volume":"37","author":"L Friberg","year":"2016","unstructured":"Friberg L, Tabrizi F, Englund A. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J. 2016;37(31):2478\u201387.","journal-title":"Eur Heart J"},{"issue":"5","key":"932_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.hrthm.2017.02.001","volume":"14","author":"W Saliba","year":"2017","unstructured":"Saliba W, Schliamser JE, Lavi I, Barnett-Griness O, Gronich N, Rennert G. Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: a propensity score-matched analysis. Heart Rhythm. 2017;14(5):635\u201342.","journal-title":"Heart Rhythm."},{"issue":"6","key":"932_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/2047487315599892","volume":"23","author":"JL Pallisgaard","year":"2016","unstructured":"Pallisgaard JL, Schjerning AM, Lindhardt TB, Procida K, Hansen ML, Torp-Pedersen C, et al. Risk of atrial fibrillation in diabetes mellitus: a nationwide cohort study. Eur J Prev Cardiol. 2016;23(6):621\u20137.","journal-title":"Eur J Prev Cardiol."},{"issue":"3","key":"932_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijcard.2005.02.050","volume":"105","author":"MR Movahed","year":"2005","unstructured":"Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005;105(3):315\u20138.","journal-title":"Int J Cardiol"},{"key":"932_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1475-2840-7-28","volume":"7","author":"OE Johansen","year":"2008","unstructured":"Johansen OE, Brustad E, Enger S, Tveit A. Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects. Cardiovasc Diabetol. 2008;7:28.","journal-title":"Cardiovasc Diabetol."},{"issue":"6","key":"932_CR15","doi-asserted-by":"publisher","first-page":"e004705","DOI":"10.1161\/JAHA.116.004705","volume":"6","author":"YS Baek","year":"2017","unstructured":"Baek YS, Yang PS, Kim TH, Uhm JS, Park J, Pak HN, et al. Associations of abdominal obesity and new-onset atrial fibrillation in the general population. J Am Heart Assoc. 2017;6(6):e004705.","journal-title":"J Am Heart Assoc."},{"issue":"5","key":"932_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.amjmed.2005.01.031","volume":"118","author":"L Frost","year":"2005","unstructured":"Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med. 2005;118(5):489\u201395.","journal-title":"Am J Med"},{"key":"932_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijcard.2016.04.036","volume":"215","author":"SH Kang","year":"2016","unstructured":"Kang SH, Choi EK, Han KD, Lee SR, Lim WH, Cha MJ, et al. Underweight is a risk factor for atrial fibrillation: a nationwide population-based study. Int J Cardiol. 2016;215:449\u201356.","journal-title":"Int J Cardiol"},{"issue":"21","key":"932_CR18","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.jacc.2010.02.029","volume":"55","author":"UB Tedrow","year":"2010","unstructured":"Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women\u2019s health study). J Am Coll Cardiol. 2010;55(21):2319\u201327.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"932_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jacc.2006.08.060","volume":"49","author":"AS Gami","year":"2007","unstructured":"Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49(5):565\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"932_CR20","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","volume":"292","author":"TJ Wang","year":"2004","unstructured":"Wang TJ, Parise H, Levy D, D\u2019Agostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471\u20137.","journal-title":"JAMA"},{"issue":"1","key":"932_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/pedi.12787","volume":"20","author":"JI Malone","year":"2019","unstructured":"Malone JI, Hansen BC. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? Pediatr Diabetes. 2019;20(1):5\u20139.","journal-title":"Pediatr Diabetes."},{"issue":"5","key":"932_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jjcc.2015.04.002","volume":"66","author":"CA Goudis","year":"2015","unstructured":"Goudis CA, Korantzopoulos P, Ntalas IV, Kallergis EM, Ketikoglou DG. Obesity and atrial fibrillation: a comprehensive review of the pathophysiological mechanisms and links. J Cardiol. 2015;66(5):361\u20139.","journal-title":"J Cardiol"},{"issue":"11","key":"932_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","volume":"271","author":"EJ Benjamin","year":"1994","unstructured":"Benjamin EJ, Levy D, Vaziri SM, D\u2019Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271(11):840\u20134.","journal-title":"JAMA."},{"issue":"2","key":"932_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/heartjnl-2011-300503","volume":"98","author":"RR Huxley","year":"2012","unstructured":"Huxley RR, Alonso A, Lopez FL, Filion KB, Agarwal SK, Loehr LR, et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the atherosclerosis risk in communities study. Heart. 2012;98(2):133\u20138.","journal-title":"Heart"},{"issue":"5","key":"932_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1536\/ihj.50.627","volume":"50","author":"H Otake","year":"2009","unstructured":"Otake H, Suzuki H, Honda T, Maruyama Y. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J. 2009;50(5):627\u201341.","journal-title":"Int Heart J."},{"issue":"1","key":"932_CR26","doi-asserted-by":"publisher","first-page":"H86","DOI":"10.1152\/ajpheart.00010.2012","volume":"303","author":"M Watanabe","year":"2012","unstructured":"Watanabe M, Yokoshiki H, Mitsuyama H, Mizukami K, Ono T, Tsutsui H. Conduction and refractory disorders in the diabetic atrium. Am J Physiol Heart Circ Physiol. 2012;303(1):H86\u201395.","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"7","key":"932_CR27","first-page":"543","volume":"12","author":"C Liu","year":"2012","unstructured":"Liu C, Fu H, Li J, Yang W, Cheng L, Liu T, et al. Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits. Anadolu Kardiyol Derg. 2012;12(7):543\u201350.","journal-title":"Anadolu Kardiyol Derg."},{"issue":"4","key":"932_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1540-8167.2007.01037.x","volume":"19","author":"T Kato","year":"2008","unstructured":"Kato T, Yamashita T, Sekiguchi A, Tsuneda T, Sagara K, Takamura M, et al. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat. J Cardiovasc Electrophysiol. 2008;19(4):415\u201320.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"34","key":"932_CR29","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1093\/eurheartj\/ehx316","volume":"38","author":"SS Lee","year":"2017","unstructured":"Lee SS, Ae Kong K, Kim D, Lim YM, Yang PS, Yi JE, et al. Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea. Eur Heart J. 2017;38(34):2599\u2013607.","journal-title":"Eur Heart J"},{"issue":"1","key":"932_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12933-017-0604-9","volume":"16","author":"BS Karam","year":"2017","unstructured":"Karam BS, Chavez-Moreno A, Koh W, Akar JG, Akar FG. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):120.","journal-title":"Cardiovasc Diabetol."},{"issue":"20","key":"932_CR31","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","volume":"65","author":"RK Pathak","year":"2015","unstructured":"Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159\u201369.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"932_CR32","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.jacc.2017.09.002","volume":"70","author":"CJ Lavie","year":"2017","unstructured":"Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol. 2017;70(16):2022\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"932_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/jdi.12446","volume":"7","author":"T Hirano","year":"2016","unstructured":"Hirano T, Mori Y. Anti-atherogenic and anti-inflammatory properties of glucagon-like peptide-1, glucose-dependent insulinotropic polypepide, and dipeptidyl peptidase-4 inhibitors in experimental animals. J Diabetes Investig. 2016;7(Suppl 1):80\u20136.","journal-title":"J Diabetes Investig."},{"issue":"1","key":"932_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12933-017-0640-5","volume":"16","author":"CY Chang","year":"2017","unstructured":"Chang CY, Yeh YH, Chan YH, Liu JR, Chang SH, Lee HF, et al. Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan. Cardiovasc Diabetol. 2017;16(1):159.","journal-title":"Cardiovasc Diabetol."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0932-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-019-0932-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0932-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T23:15:45Z","timestamp":1601421345000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-019-0932-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["932"],"URL":"https:\/\/doi.org\/10.1186\/s12933-019-0932-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]},"assertion":[{"value":"9 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Korea University Medical Center Anam Hospital and informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}